Estrogen and Alzheimer's disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1351, 2002-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Estrogen and Alzheimer's Disease: The Story So Far

By Cholerton Brenna Gleason Carey E. Baker Laura D. Asthana Sanjay

Drugs & Aging, Vol. 19, Iss. 6, 2002-01 ,pp. : 405-427

Adis International

Access to resources Recommend Favorite

Impact of Estrogen Therapy on Alzheimer's Disease: A Fork in the Road?

By Brinton R.D.

CNS Drugs, Vol. 18, Iss. 7, 2004-01 ,pp. : 405-422

Adis International

Access to resources Recommend Favorite

Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 4, 2004-08 ,pp. : 281-285

Bentham Science Publishers

Access to resources Recommend Favorite

The Estrogen Myth: Potential Use of Gonadotropin-Releasing Hormone Agonists for the Treatment of Alzheimer's Disease

By Casadesus Gemma

Drugs in R&D, Vol. 7, Iss. 3, 2006-01 ,pp. : 187-193

Adis International

Access to resources Recommend Favorite

Galantamine for Alzheimer's disease

By Prvulovic David Hampel Harald Pantel Johannes

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 345-354

Informa Healthcare

Access to resources Recommend Favorite